We are live on ! Find out more
AVNS

Avanos Medical
AVNS

Delisted

AVNS was delisted on the 24th of July, 2026.

Back to rankings

287 hedge funds and large institutions have $1.3B invested in Avanos Medical in 2023 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 79 increasing their positions, 81 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $98K | Put options by funds: $42K

27% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 26

19% more capital invested

Capital invested by funds: $1.1B → $1.3B (+$209M)

1.34% more ownership

Funds ownership: 93.22% → 94.55% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less funds holding

Funds holding: 288 → 287 (-1)

2% less repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 81

Holders
287
Holders Change
-1
Holders Change %
-0.35%
% of All Funds
4.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
33
Increased
79
Reduced
81
Closed
26
Calls
$98K
Puts
$42K
Net Calls
+$56K
Net Calls Change
+$23K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$36M
2
Macquarie Group
Macquarie Group
Australia
+$10.2M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$8.19M
4
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$5.56M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
WHG
Westwood Holdings Group
Texas
-$19.5M
2
Goldman Sachs
Goldman Sachs
New York
-$11M
3
Pacer Advisors
Pacer Advisors
Pennsylvania
-$6.47M
4
Citadel Advisors
Citadel Advisors
Florida
-$4.58M
5
N
Nuveen
North Carolina
-$4.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
BAM
201
Byrne Asset Management
New Jersey
$3K +$2.9K +100 New
TIM
202
Tortoise Investment Management
New York
$2.96K – – –
ARS
203
Adirondack Retirement Specialists
New York
$2.92K – – –
LC
204
Lindbrook Capital
California
$2.77K -$1.07K -37 -28%
AAG
205
Armstrong Advisory Group
Massachusetts
$2.68K -$319 -11 -11%
CSPAM
206
Cary Street Partners Asset Management
Virginia
$2.56K – – –
FDCDDQ
207
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.53K – – –
MCM
208
MV Capital Management
Maryland
$2.44K +$1.1K +38 +86%
HRC
209
Hoertkorn Richard Charles
$2.32K – – –
FGAM
210
Financial Gravity Asset Management
Texas
$2.23K +$871 +30 New
SIS
211
Sound Income Strategies
Florida
$2.11K – – –
FRA
212
Front Row Advisors
California
$2K – – –
ST
213
Smithfield Trust
Pennsylvania
$2K – – –
WAS
214
Winch Advisory Services
Wisconsin
$2K – – –
AAS
215
Ameritas Advisory Services
Nebraska
$1.91K +$1.86K +64 New
ASN
216
Advisory Services Network
Georgia
$1.9K -$1.68K -58 -48%
CTA
217
Colonial Trust Advisors
South Carolina
$1.64K – – –
SWM
218
Sugarloaf Wealth Management
Georgia
$1.61K – – –
AIC
219
Archer Investment Corporation
Indiana
$1.49K – – –
BAM
220
Bellevue Asset Management
Washington
$1.49K – – –
AIM
221
Anchor Investment Management
South Carolina
$1.46K – – –
CFGS
222
Concourse Financial Group Securities
Alabama
$1.46K – – –
PSB
223
Piscataqua Savings Bank
New Hampshire
$1.19K – – –
MG
224
MilWealth Group
Wisconsin
$1.1K +$1.07K +37 New
FMII
225
Farmers & Merchants Investments Inc
Nebraska
$1.07K – – –
7 8
9
10 11

AVNS Hedge Fund Activity: Q1 2023 in Review

287 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2023, worth a combined $1.3B — up 19% from $1.1B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new AVNS positions and 26 closed out — a net gain of 7 holders — while 79 added to existing stakes and 81 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $36M. The largest seller was Westwood Holdings Group, cutting an estimated $19.5M.

  • 287 institutional investors held Avanos Medical (AVNS) as of Q1 2023, down from 288 in Q4 2022.
  • Funds reported $1.3B of Avanos Medical stock for Q1 2023, up 19% quarter-over-quarter.
  • 33 funds opened new Avanos Medical positions in Q1 2023 and 26 closed out, a net change of +7 holders.
  • The largest Avanos Medical buyer in Q1 2023 was T. Rowe Price Investment Management, an estimated $36M added.
  • The largest Avanos Medical seller in Q1 2023 was Westwood Holdings Group, an estimated $19.5M sold.

Based on aggregated 13F filings for Q1 2023.